AIM ImmunoTech Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
AIM ImmunoTech Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • AIM ImmunoTech Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $36.8M, a 19.4% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $36.8M +$5.98M +19.4% Dec 31, 2023 10-K 2024-04-01
Q4 2022 $30.8M +$7.13M +30.1% Dec 31, 2022 10-K 2024-04-01
Q4 2021 $23.7M +$14.3M +151% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $9.44M -$35M -78.8% Dec 31, 2020 10-K 2022-03-31
Q4 2019 $44.5M +$4.31M +10.7% Dec 31, 2019 10-K 2021-03-31
Q4 2018 $40.2M +$2.04M +5.34% Dec 31, 2018 10-K 2020-03-30
Q4 2017 $38.1M -$21M -35.5% Dec 31, 2017 10-K 2019-04-01
Q4 2016 $59.1M +$1.96M +3.42% Dec 31, 2016 10-K 2018-03-30
Q4 2015 $57.1M +$4.7M +8.96% Dec 31, 2015 10-K 2017-03-31
Q4 2014 $52.4M +$3.82M +7.86% Dec 31, 2014 10-K 2016-03-29
Q4 2013 $48.6M +$5.98M +14% Dec 31, 2013 10-K 2015-03-19
Q4 2012 $42.6M +$4.84M +12.8% Dec 31, 2012 10-K 2014-03-14
Q4 2011 $37.8M Dec 31, 2011 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.